Short radiation course for breast cancer shows promise
December 6, 2019 -- A shorter round of higher-dose radiation to part of the breast demonstrates promising results in women with early-stage breast cancer, according to a study published on December 5 in Lancet.
December 6, 2019 -- A shorter round of higher-dose radiation to part of the breast demonstrates promising results in women with early-stage breast cancer, according to a study published on December 5 in Lancet.
ViewRay inks deal with Elekta, Medtronic
December 4, 2019 -- Image-guided radiation therapy vendor ViewRay has signed a nonbinding memorandum of understanding to collaborate with radiation oncology vendor Elekta and device manufacturer Medtronic on MR-guided radiation therapy.
December 4, 2019 -- Image-guided radiation therapy vendor ViewRay has signed a nonbinding memorandum of understanding to collaborate with radiation oncology vendor Elekta and device manufacturer Medtronic on MR-guided radiation therapy.
Cancer patients want more info on treatment downside
November 22, 2019 -- One in three adults wish they had known more about side effects before beginning their cancer treatment, according to the results of a new survey published online November 20 in the Journal of Oncology Practice
Discuss
November 22, 2019 -- One in three adults wish they had known more about side effects before beginning their cancer treatment, according to the results of a new survey published online November 20 in the Journal of Oncology Practice
Discuss PTW unveils multipurpose QA rad therapy phantom
November 20, 2019 -- Dosimetry firm PTW has introduced Ruby, a modular, multipurpose phantom designed to provide quality assurance (QA) evaluation of the entire radiotherapy treatment chain.
November 20, 2019 -- Dosimetry firm PTW has introduced Ruby, a modular, multipurpose phantom designed to provide quality assurance (QA) evaluation of the entire radiotherapy treatment chain.
DOSIsoft gets FDA nod for MU2net software
November 11, 2019 -- Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its MU2net software for independent secondary dose calculation for patient quality assurance.
November 11, 2019 -- Radiation oncology and nuclear medicine software developer DOSIsoft has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its MU2net software for independent secondary dose calculation for patient quality assurance.
Navidea signs immunotherapy deal with IMV
November 7, 2019 -- Radiopharmaceutical developer Navidea Biopharmaceuticals has signed an agreement with biopharmaceutical company IMV to explore a preclinical research collaboration that could combine each company's immunotherapy technologies.
November 7, 2019 -- Radiopharmaceutical developer Navidea Biopharmaceuticals has signed an agreement with biopharmaceutical company IMV to explore a preclinical research collaboration that could combine each company's immunotherapy technologies.
Sensus' revenues slip in Q3
November 7, 2019 -- Lower sales of its robotic intraoperative radiation therapy system adversely affected the revenue picture at superficial radiation therapy provider Sensus Healthcare in the third quarter of 2019.
November 7, 2019 -- Lower sales of its robotic intraoperative radiation therapy system adversely affected the revenue picture at superficial radiation therapy provider Sensus Healthcare in the third quarter of 2019.
Hahn nominated to lead FDA as commissioner
November 1, 2019 -- Radiation oncologist Dr. Stephen Hahn has been nominated as commissioner of the U.S. Food and Drug Administration (FDA). The nomination is drawing plaudits from the American Society for Radiation Oncology and other cancer organizations.
Discuss
November 1, 2019 -- Radiation oncologist Dr. Stephen Hahn has been nominated as commissioner of the U.S. Food and Drug Administration (FDA). The nomination is drawing plaudits from the American Society for Radiation Oncology and other cancer organizations.
Discuss Navidea highlights rheumatoid arthritis results
October 30, 2019 -- Radiopharmaceutical developer Navidea Biopharmaceuticals said that interim analysis of an ongoing phase IIB study shows positive results from using its technetium-99m tilmanocept radiopharmaceutical in patients with rheumatoid arthritis.
October 30, 2019 -- Radiopharmaceutical developer Navidea Biopharmaceuticals said that interim analysis of an ongoing phase IIB study shows positive results from using its technetium-99m tilmanocept radiopharmaceutical in patients with rheumatoid arthritis.
Varian posts continued revenue gains in Q4, fiscal 2019
October 24, 2019 -- Radiation therapy firm Varian Medical Systems reported a 10% increase in revenue in both its fourth quarter and fiscal 2019, due in large part to growth in orders for its oncology products.
October 24, 2019 -- Radiation therapy firm Varian Medical Systems reported a 10% increase in revenue in both its fourth quarter and fiscal 2019, due in large part to growth in orders for its oncology products.
Special Feature
IMV: Imaging boosts precision in radiation therapy
Radiation therapy is a relatively stable market, with procedure volume growing at an average annual rate of 2%. But major technological changes in radiation oncology are brewing under the surface, according to a new report by IMV Medical Information Division. Read more
VENDOR CONNECT